Skip to main content
PHAT
NASDAQ Life Sciences

Phathom Completes Enrollment for Phase 2 EoE Trial, Topline Data Expected Q4 2026

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.64
Mkt Cap
$852.591M
52W Low
$7.61
52W High
$18.31
52W Position info
40% above low
Off High info
42% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

PHAT sits 40% above its 52-week low of $7.61.

Summary

Phathom Pharmaceuticals has completed enrollment of 95 patients in its Phase 2 pHalcon-EoE-201 trial evaluating VOQUEZNA for eosinophilic esophagitis. This follows an 8-K filed earlier today announcing the same milestone. Completing enrollment is a significant step in clinical development, de-risking the trial execution and moving the company closer to potential new indications for its drug. Topline results from this trial are anticipated in Q4 2026, which will be a key data readout for the company.

At the time of this announcement, PHAT was trading at $10.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $852.6M. The 52-week trading range was $7.61 to $18.31. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PHAT - Latest Insights

PHAT
Oct 29, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.65
Real-time Price: $5.50 info
Change: -$1.15 (-17%) info
Market Cap: $447.103M info
PHAT
Oct 29, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.65
Real-time Price: $5.50 info
Change: -$1.15 (-17%) info
Market Cap: $447.103M info
PHAT
Oct 26, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $5.50 info
Change: $0 (0%) info
Market Cap: $447.103M info
PHAT
Oct 26, 2026, 4:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $5.50 info
Change: $0 (0%) info
Market Cap: $447.103M info
PHAT
Oct 23, 2026, 4:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.86
Real-time Price: $5.50 info
Change: -$1.36 (-20%) info
Market Cap: $447.103M info